You can only shake your head and hope your own judgement will be vindicated.
I read the Chairmans report in the newly released 2010 Annual Report in search of clues in relation to the future direction of the Roche collaboration.
"These screens [of our phylomer libraries] generated very encouraging results, which are currently being reviewed by Roche, and we are in discussions regarding the next phase of the collaboration," said Dr Doug Wilson.
Reading between the lines, it looks extremely promising that Roche will sign on for a major pharmaceutical deal - the second drug discovery phase.
I also note from the 4C quarterly report that Phylogica recorded a net operating cash flow for the quarter. Worth a celebratory drink for the staff in Perth. Meanwhile Dr Paul Watt has just completed his presentation at the 3rd Annual Proteins-Congress in Germany. Its all happening.
PYC Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)